Tag Archives: drug trial shows rectal cancer in remission in all patients

An experimental drug appeared to rid people of rectal cancer in an unprecedented study, according to The New York Times. A group comprising 18 patients took a drug called Dostarlimab for around six months, and in the end, every one of them saw their tumours disappear. In conversation with the New York Times, Dr Luis Diaz, an author of a paper, said …

Read More »